Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2017.03.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epimutational Profile of Hematologic Malignancies as Attractive Target for New Epigenetic Therapies

Oncotarget
Oncology
2016English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults With Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Editorial: The Emerging Role for PP2A in Hematologic Malignancies

Frontiers in Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy